Q32 Bio Inc.

QTTB · Nasdaq · SIC 2834: Pharmaceutical Preparations
113
SEC Filings

Business Summary

1 Item 1A. Risk Factors 28 Item 1B. Unresolved Staff Comments 74 Item 1C. Cybersecurity 74 Item 2. Properties 75 Item 3. Legal Proceedings 75 Item 4. Mine Safety Disclosures 75 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 76 Item 6. [Reserved] 76 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 77 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 92 Item 8....

Next Earnings

Q2 FY2026 — expected 2026-08-06

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionQTTBdiscussed_in_filing Cybersecurity
topic_mentionQTTBdiscussed_in_filing Cybersecurity
topic_mentionQTTBdiscussed_in_filing Cybersecurity
topic_mentionQTTBdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-102025-12-310001193125-26-099339EDGAR104K words
2025-03-112024-12-310000950170-25-036823EDGAR—
2024-03-132023-12-310000950170-24-030478EDGAR—
2023-03-092022-12-310000950170-23-006995EDGAR—
2022-03-232021-12-310000950170-22-004401EDGAR—
2021-03-112020-12-310001564590-21-012490EDGAR—
2020-03-122019-12-310001564590-20-010441EDGAR—
2019-03-122018-12-310001564590-19-007250EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001193125-25-278812EDGAR76K words
2025-08-062025-06-300000950170-25-103530EDGAR—
2025-05-082025-03-310000950170-25-066371EDGAR—
2024-11-072024-09-300000950170-24-122785EDGAR—
2024-08-082024-06-300000950170-24-093305EDGAR—
2024-05-092024-03-310000950170-24-056273EDGAR—
2023-11-142023-09-300000950170-23-063667EDGAR—
2023-08-142023-06-300000950170-23-042360EDGAR—
2023-05-112023-03-310000950170-23-021177EDGAR—
2022-11-102022-09-300000950170-22-024431EDGAR—
2022-08-152022-06-300000950170-22-017367EDGAR—
2022-05-162022-03-310000950170-22-010065EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-270001193125-26-129431EDGAR26K words
2026-03-100001193125-26-099328EDGAR—
2026-02-170001193125-26-054711EDGAR—
2025-12-190001193125-25-326821EDGAR—
2025-12-010001193125-25-303115EDGAR—
2025-11-130001193125-25-278805EDGAR—
2025-10-210001193125-25-244262EDGAR—
2025-08-060000950170-25-103526EDGAR—
2025-06-250001193125-25-146179EDGAR—
2025-06-170001193125-25-142039EDGAR—

113 total filings indexed. 83 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001661998
TickerQTTB
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 0f8671a425efdfaa575f8f1c0284d9652867ea5ff73a8b0a0612772b4527e94b
parent: 58776eb8e0a8acbd30ce8e8ebac845c188488273420e7d87952aa310dff34970
content hash: 828c77f557c44fa40203701e450b26220a7cc4f0711e40e6ced5b72c4e9ffde3
signed: 2026-04-13T04:47:06.002Z
sources: 20 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf